Presentation TCT 2016 Should Clinical Trial Interpretation Be Dominated by A P Value of 0.05 for the Primary Endpoint? Presenter: Gregg W. Stone October 30, 2016 REGISTER for free or LOG IN to view this content Presentation TCT 2016 Quality Up Next Presentation TCT 2016 Levels of Evidence: Single-center vs Multicenter Trials Presenter: Roxana Mehran October 30, 2016 More slides + Presentation TCT 2016 Clinical Trial Interpretation: Relative vs Absolute Differences Presenter: John A. Bittl October 30, 2016 Presentation TCT 2016 Importance of Unmeasured Confounders in Observational Registries: ASCERT and Other Examples Presenter: Kirk N. Garratt October 30, 2016 We Recommend
Presentation TCT 2016 Levels of Evidence: Single-center vs Multicenter Trials Presenter: Roxana Mehran October 30, 2016
Presentation TCT 2016 Clinical Trial Interpretation: Relative vs Absolute Differences Presenter: John A. Bittl October 30, 2016
Presentation TCT 2016 Importance of Unmeasured Confounders in Observational Registries: ASCERT and Other Examples Presenter: Kirk N. Garratt October 30, 2016